Adenocarcinoma of the lung medical therapy stage I: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
==Stage I== | ==Stage I== | ||
* Shown below is the algorithm on the treatment of the stage I non-small cell lung cancer based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref>Lung cancer. National Comprehensive Cancer Network 2015. http://www.nccn.org/professionals/default.aspx</ref> | * Shown below is the algorithm on the treatment of the stage I [[Non small cell lung cancer|non-small cell lung cancer]] based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref>Lung cancer. National Comprehensive Cancer Network 2015. http://www.nccn.org/professionals/default.aspx</ref> | ||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | | | | A01 | | |A01=In the [[tumor]] central | {{familytree | | | | | | | | | | A01 | | |A01=In the [[tumor]] central or peripheral?}} | ||
{{familytree | | | | | | |,|-|-|-|^|-|-|.| | | | |}} | {{familytree | | | | | | |,|-|-|-|^|-|-|.| | | | |}} | ||
{{familytree | | | | | | B01 | | | | | B02 | | | B01=Peripheral|B02=Central}} | {{familytree | | | | | | B01 | | | | | B02 | | | B01=Peripheral|B02=Central}} | ||
Line 26: | Line 26: | ||
* If not done, order [[PET]] scan or [[CT scan]]}} | * If not done, order [[PET]] scan or [[CT scan]]}} | ||
{{familytree | | | |!| | | | | | | |!| | | | |}} | {{familytree | | | |!| | | | | | | |!| | | | |}} | ||
{{familytree | | | F01 | | | | | | F02 | | | | | F01=Does the pathological evaluation showed positive disease in the mediastinal [[lymph nodes]]?|F02=Does the pathological evaluation showed positive disease in the mediastinal [[lymph nodes]]?}} | {{familytree | | | F01 | | | | | | F02 | | | | | F01=Does the [[pathological]] evaluation showed positive disease in the mediastinal [[lymph nodes]]?|F02=Does the pathological evaluation showed positive disease in the mediastinal [[lymph nodes]]?}} | ||
{{familytree | |,|-|^|-|.| | | |,|-|^|-|.| | |}} | {{familytree | |,|-|^|-|.| | | |,|-|^|-|.| | |}} | ||
{{familytree | G01 | | G02 | | G03 | | G04 | | G01=Yes|G02=No|G03=Yes|G04=No}} | {{familytree | G01 | | G02 | | G03 | | G04 | | G01=Yes|G02=No|G03=Yes|G04=No}} | ||
Line 34: | Line 34: | ||
{{familytree | | | I01 | | I02 | | I03 | | I04 | | | I01=Yes|I02=No|I03=Yes|I04=No}} | {{familytree | | | I01 | | I02 | | I03 | | I04 | | | I01=Yes|I02=No|I03=Yes|I04=No}} | ||
{{familytree | | | |!| | | |!| | | |!| | | |!| | | |}} | {{familytree | | | |!| | | |!| | | |!| | | |!| | | |}} | ||
{{familytree | | | J01 | | J02 | | J03 | | J04 | | | J01=Surgical resection + [[lymph node]] dissection|J02=[[Non small cell carcinoma of the lung radiation therapy#Stereotactic Ablative Radiotherapy Usual Dosage|stereotactic ablative radiation therapy]]|J03=Surgical resection + [[lymph node]] dissection|J04=Does the patient presents metastasis to ipsilateral peribronchial and/or | {{familytree | | | J01 | | J02 | | J03 | | J04 | | | J01=Surgical resection + [[lymph node]] dissection|J02=[[Non small cell carcinoma of the lung radiation therapy#Stereotactic Ablative Radiotherapy Usual Dosage|stereotactic ablative radiation therapy]]|J03=Surgical resection + [[lymph node]] dissection|J04=Does the patient presents metastasis to ipsilateral peribronchial and/or hilar nodesand intrapulmonary nodes (N1)?}} | ||
{{familytree | | | | | | | | | | | | | |,|-|^|-|.| | |}} | {{familytree | | | | | | | | | | | | | |,|-|^|-|.| | |}} | ||
{{familytree | | | | | | | | | | | | | K01 | | K02 | | |K01=Yes|K02=No}} | {{familytree | | | | | | | | | | | | | K01 | | K02 | | |K01=Yes|K02=No}} | ||
Line 40: | Line 40: | ||
{{familytree | | | | | | | | | | | | | L01 | | L02 | | | L01=[[Non small cell carcinoma of the lung chemotherapy#Chemotherapy plus radiation therapy|chemotherapy + radiation therapy]]|L02=[[Non small cell carcinoma of the lung radiation therapy#Stereotactic Ablative Radiotherapy Usual Dosage|stereotactic ablative radiation therapy]]<br>Adjuvant [[Non small cell carcinoma of the lung chemotherapy|chemotherapy]] should be added for high-risk stages}} | {{familytree | | | | | | | | | | | | | L01 | | L02 | | | L01=[[Non small cell carcinoma of the lung chemotherapy#Chemotherapy plus radiation therapy|chemotherapy + radiation therapy]]|L02=[[Non small cell carcinoma of the lung radiation therapy#Stereotactic Ablative Radiotherapy Usual Dosage|stereotactic ablative radiation therapy]]<br>Adjuvant [[Non small cell carcinoma of the lung chemotherapy|chemotherapy]] should be added for high-risk stages}} | ||
{{familytree/end}} | {{familytree/end}} | ||
==References== | ==References== |
Latest revision as of 13:51, 6 March 2018
Adenocarcinoma of the Lung Microchapters |
Differentiating Adenocarcinoma of the Lung from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Adenocarcinoma of the lung medical therapy stage I On the Web |
American Roentgen Ray Society Images of Adenocarcinoma of the lung medical therapy stage I |
Adenocarcinoma of the lung medical therapy stage I in the news |
Risk calculators and risk factors for Adenocarcinoma of the lung medical therapy stage I |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Stage I
- Shown below is the algorithm on the treatment of the stage I non-small cell lung cancer based on the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[1]
In the tumor central or peripheral? | |||||||||||||||||||||||||||||||||||||||||||
Peripheral | Central | ||||||||||||||||||||||||||||||||||||||||||
Is the tumor T1 or T2a? | |||||||||||||||||||||||||||||||||||||||||||
T1ab, N0 | T2a, N0 | T1ab-2a, N0 | |||||||||||||||||||||||||||||||||||||||||
Perform a pretreatment evaluation
| Perform a pretreatment evaluation | ||||||||||||||||||||||||||||||||||||||||||
Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | Does the pathological evaluation showed positive disease in the mediastinal lymph nodes? | ||||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Click here for the stage III treatment | Is the tumor operable? | Click here for the stage III treatment | Is the tumor operable? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | Yes | No | ||||||||||||||||||||||||||||||||||||||||
Surgical resection + lymph node dissection | stereotactic ablative radiation therapy | Surgical resection + lymph node dissection | Does the patient presents metastasis to ipsilateral peribronchial and/or hilar nodesand intrapulmonary nodes (N1)? | ||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||
chemotherapy + radiation therapy | stereotactic ablative radiation therapy Adjuvant chemotherapy should be added for high-risk stages | ||||||||||||||||||||||||||||||||||||||||||
References
- ↑ Lung cancer. National Comprehensive Cancer Network 2015. http://www.nccn.org/professionals/default.aspx